Market Overview:
The global primary antibody market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies and polyclonal antibodies due to their high specificity and affinity. Additionally, the increasing use of primary antibodies in hospital, life sciences, and laboratory applications is also contributing to the growth of this market. However, the high cost associated with the procurement of these antibodies may restrain the growth of this market during the forecast period. On basis on type, monoclonal antibody segment is projected to account for majority share in global primary antibody market by 2030 owing its advantages such as high specificity and affinity over polyclonal antibodies segments. On basis on application Hospital segment accounted for largest share followed by Life Sciences & Laboratory segments respectively in 2017 majorly due rising incidences chronic diseases that requires diagnosis through immunoassays which are performed using primary antibodies reagents kit globally .
Product Definition:
A primary antibody is an immunoglobulin molecule that specifically binds to a particular antigen. It is produced by the B cells of the immune system in response to an infection or vaccination. The primary antibody recognizes and binds to a specific epitope on the antigen, initiating an immune response.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are produced by the body's immune system to fight against bacteria, viruses or other harmful substances. The most common symptoms of monoclonal antibody deficiency include chronic fatigue syndrome, fibromyalgia and arthritis. However; there are various other less known symptoms including itchy scalp, swelling in hands & feet, frequent infections and diarrhea among others.
Polyclonal Antibody:
Polyclonal antibodies are made by B cells and are used in the detection of cancer or infections. They work by binding to an antigen and so they can only be used for diseases that have an antigen as a common feature. The most important use of polyclonal antibodies is in the detection of cancer, where they are employed with other diagnostic tests to provide confirmation for a positive diagnosis.
Application Insights:
The hospital application segment accounted for the largest share of more than 60.0% in 2017. The growth can be attributed to the rising prevalence of chronic diseases, such as cancer, diabetes and autoimmune disorders that require long-term care and management. In addition, a rise in the number of surgeries is also expected to contribute toward segment growth during the forecast period.
The life sciences sector is anticipated to witness significant growth over the forecast period owing to increasing investments by companies engaged in R&D activities related with antibodies and immunology products for diagnosis or treatment of various life-threatening conditions, such as AIDS/HIV infection & disease progression; multiple sclerosis; rheumatoid arthritis; osteoporosis & osteoarthritis; Crohn¢â‚¬â„¢s disease & ulcerative colitis; kidney diseases (nephrological disorders) including nephrotic syndrome & dialysis); gastrointestinal disorders including food allergies & intolerances.
Regional Analysis:
North America dominated the global primary antibody market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, advanced healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region are some factors that can be attributed for its large share. Moreover, the easy availability of animal-derived sources such as monoclonal antibodies is also expected to contribute towards its substantial revenue share over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by leading players and an increasing number of clinical trials being conducted in this region due to various benefits associated with it such as lower operational costs and less stringent regulations regarding approval for conducting clinical trials than other parts of world. In addition, Asia Pacific has been observed attracting most significant numbers or drug resistant tuberculosis (TB) patients from other regions owing to lack or effective treatment options against multidrug-resistant TB infection which further contributes toward regional growth prospects during the projected time frame.
Growth Factors:
- Increasing prevalence of autoimmune diseases and cancer is expected to drive the growth of primary antibody market.
- Rising demand for monoclonal antibodies for diagnosis and treatment of various diseases is another major factor that would fuel the growth of this market in near future.
- Growing research and development investments by pharmaceutical companies for discovery and development of novel therapeutics is anticipated to create lucrative opportunities for key players operating in primary antibody market.
- Proliferation of contract research organizations (CROs) is also expected to boost the demand for primary antibodies over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Primary Antibody Market Research Report
By Type
Monoclonal Antibodies, Polyclonal Antibody
By Application
Hospital, Life Sciences, Laboratory
By Companies
Bio-Rad, Biorbyt, Abcam, Thermo Fisher Scientific, Creative Diagnostics, Novus Biologicals, SouthernBiotech, Boster Bio, OriGene, Genscript Biotech, Proteintech, Roche Diagnostics, HyTest
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Primary Antibody Market Report Segments:
The global Primary Antibody market is segmented on the basis of:
Types
Monoclonal Antibodies, Polyclonal Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Life Sciences, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Biorbyt
- Abcam
- Thermo Fisher Scientific
- Creative Diagnostics
- Novus Biologicals
- SouthernBiotech
- Boster Bio
- OriGene
- Genscript Biotech
- Proteintech
- Roche Diagnostics
- HyTest
Highlights of The Primary Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Polyclonal Antibody
- By Application:
- Hospital
- Life Sciences
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Primary Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Primary antibody is the first antibody that a person produces in response to an antigen.
Some of the major companies in the primary antibody market are Bio-Rad, Biorbyt, Abcam, Thermo Fisher Scientific, Creative Diagnostics, Novus Biologicals, SouthernBiotech, Boster Bio, OriGene, Genscript Biotech, Proteintech, Roche Diagnostics, HyTest.
The primary antibody market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Primary Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Primary Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Primary Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Primary Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Primary Antibody Market Size & Forecast, 2020-2028
4.5.1 Primary Antibody Market Size and Y-o-Y Growth
4.5.2 Primary Antibody Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Polyclonal Antibody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Life Sciences
6.2.3 Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Primary Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Primary Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Polyclonal Antibody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Life Sciences
9.10.3 Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Polyclonal Antibody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Life Sciences
10.10.3 Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Polyclonal Antibody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Life Sciences
11.10.3 Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Polyclonal Antibody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Life Sciences
12.10.3 Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Polyclonal Antibody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Life Sciences
13.10.3 Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Primary Antibody Market: Competitive Dashboard
14.2 Global Primary Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 Biorbyt
14.3.3 Abcam
14.3.4 Thermo Fisher Scientific
14.3.5 Creative Diagnostics
14.3.6 Novus Biologicals
14.3.7 SouthernBiotech
14.3.8 Boster Bio
14.3.9 OriGene
14.3.10 Genscript Biotech
14.3.11 Proteintech
14.3.12 Roche Diagnostics
14.3.13 HyTest
